Most Read Articles
one year ago
Cetuximab as third line therapy provided survival benefits and maintained quality of life in patients with metastatic colorectal cancers (mCRC) who responded unsuccessfully to prior chemotherapy, a study conducted in a single institution has shown.
Jairia Dela Cruz, 6 months ago
Regimens containing sofosbuvir and velpatasvir are the best option for treating patients with hepatitis C virus (HCV) genotype 3 infection, according to the results of a network meta-analysis. Furthermore, ribavirin should be considered in select patients as the agent produces significant increases in sustained virological response (SVR) rates.
one year ago
Daily oral HIV pre-exposure prophylaxis with emtricitabine and tenofovir disoproxil fumarate may be safe in hepatitis B virus (HBV)-infected individuals, a study reported.
Pearl Toh, one year ago
Treatment with eluxadoline, a new oral medication, relieved two major symptoms of irritable bowel syndrome with diarrhoea (IBS-D) — abdominal pain and diarrhoea, according to a study based on two phase III randomized controlled trials. [N Engl J Med 2016;374:242-253]

Case studies: Hepatorenal syndrome

5 months ago
An expert panel meeting on hepatorenal syndrome (HRS) was recently convened in Kuala Lumpur with the aim of discussing management practices in different hospital settings. Chaired by Professor Sanjiv Mahadeva, consultant gastroenterologist, University Malaya Medical Centre, the meeting saw local and regional experts share HRS cases they have encountered in their practice.

Related MIMS Drugs

Editor's Recommendations
Most Read Articles
one year ago
Cetuximab as third line therapy provided survival benefits and maintained quality of life in patients with metastatic colorectal cancers (mCRC) who responded unsuccessfully to prior chemotherapy, a study conducted in a single institution has shown.
Jairia Dela Cruz, 6 months ago
Regimens containing sofosbuvir and velpatasvir are the best option for treating patients with hepatitis C virus (HCV) genotype 3 infection, according to the results of a network meta-analysis. Furthermore, ribavirin should be considered in select patients as the agent produces significant increases in sustained virological response (SVR) rates.
one year ago
Daily oral HIV pre-exposure prophylaxis with emtricitabine and tenofovir disoproxil fumarate may be safe in hepatitis B virus (HBV)-infected individuals, a study reported.
Pearl Toh, one year ago
Treatment with eluxadoline, a new oral medication, relieved two major symptoms of irritable bowel syndrome with diarrhoea (IBS-D) — abdominal pain and diarrhoea, according to a study based on two phase III randomized controlled trials. [N Engl J Med 2016;374:242-253]